The following post was written by a former research fellow in the lab of Piero Anversa to whom we’ve promised confidentiality. Anversa has previously told us that he cannot comment because of an ongoing investigation.
Regular readers of Retraction Watch will note the recent news regarding the work conducted in the laboratory of Piero Anversa at Brigham and Women’s Hospital, a Harvard Medical School affiliate. In the early 2000s, his laboratory published a series of papers regarding the regenerative qualities of bone marrow-derived and cardiac-resident “stem cells.”
Those initial findings, as well as the research conducted since those early studies, have always been surrounded by controversy, as many have been unsuccessful in efforts to replicate their results. Controversy among competitors is not uncommon in our profession, but this particular one has blossomed into a formal investigation of their findings, and has, to date, led to the retraction of one paper and an expression of concern about another. Continue reading Braggadacio, information control, and fear: Life inside a Brigham stem cell lab under investigation
